Stefan Groschel

Heidelberg, BW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications

High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma.

High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma.

Journal: Journal of ovarian research
Published: March 23, 2023

Cellular and metabolic characteristics of pre-leukemic hematopoietic progenitors with GATA2 haploinsufficiency.

Cellular and metabolic characteristics of pre-leukemic hematopoietic progenitors with GATA2 haploinsufficiency.

Journal: Haematologica
Published: October 16, 2022

Concurrent light chain amyloidosis and proximal tubulopathy: Insights into different aggregation behavior-A case report.

Concurrent light chain amyloidosis and proximal tubulopathy: Insights into different aggregation behavior-A case report.

Journal: EJHaem
Published: August 02, 2022

Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial.

Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 08, 2022

EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy.

EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy.

Journal: BMC cancer
Published: June 14, 2021

The leukemic oncogene EVI1 hijacks a MYC super-enhancer by CTCF-facilitated loops.

The leukemic oncogene EVI1 hijacks a MYC super-enhancer by CTCF-facilitated loops.

Journal: Nature communications
Published: June 10, 2021

Derepression of retroelements in acute myeloid leukemia with 3q aberrations.

Derepression of retroelements in acute myeloid leukemia with 3q aberrations.

Journal: Haematologica
Published: December 09, 2020

Identification of therapeutic targets of the hijacked super-enhancer complex in EVI1-rearranged leukemia.

Identification of therapeutic targets of the hijacked super-enhancer complex in EVI1-rearranged leukemia.

Journal: Leukemia
Published: July 02, 2020

Hematopoietic stem and progenitor cell-restricted Cdx2 expression induces transformation to myelodysplasia and acute leukemia.

Hematopoietic stem and progenitor cell-restricted Cdx2 expression induces transformation to myelodysplasia and acute leukemia.

Journal: Nature communications
Published: August 05, 2019

RUNX1-ETO Depletion in t(8;21) AML Leads to C/EBPα- and AP-1-Mediated Alterations in Enhancer-Promoter Interaction.

RUNX1-ETO Depletion in t(8;21) AML Leads to C/EBPα- and AP-1-Mediated Alterations in Enhancer-Promoter Interaction.

Journal: Cell reports
Published: October 31, 2018

Defective homologous recombination DNA repair as therapeutic target in advanced chordoma.

Defective homologous recombination DNA repair as therapeutic target in advanced chordoma.

Journal: Nature communications
Published: May 07, 2018

Temporal autoregulation during human PU.1 locus SubTAD formation.

Temporal autoregulation during human PU.1 locus SubTAD formation.

Journal: Blood
Published: February 20, 2018
Showing 1-12 of 27

Last Updated: 09/26/2026